ReleaseWire

Global Markets Direct's, 'Bind Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Bind Therapeutics, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Zymeworks Inc. - Product Pipeline Review - 2014', provides an overview of the Zymeworks Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'United Therapeutics Corporation - Product Pipeline Review - 2014', provides an overview of the United Therapeutics Corporation's pharmaceutical research and development focus.

Global Markets Direct's, 'Sunesis Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Sunesis Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'GeNeuro SA - Product Pipeline Review - 2014', provides an overview of the GeNeuro SA's pharmaceutical research and development focus.

Global Markets Direct's, 'Humabs BioMed SA - Product Pipeline Review - 2014', provides an overview of the Humabs BioMed SA's pharmaceutical research and development focus.

Global Markets Direct's, 'Wellstat Vaccines, LLC - Product Pipeline Review - 2014', provides an overview of the Wellstat Vaccines, LLC's pharmaceutical research and development focus.

Global Markets Direct's, 'Convergence Pharmaceuticals Ltd. - Product Pipeline Review - 2014', provides an overview of the Convergence Pharmaceuticals Ltd.'s pharmaceutical research and development focus.

Global Markets Direct's, 'GeneCure LLC - Product Pipeline Review - 2014', provides an overview of the GeneCure LLC's pharmaceutical research and development focus.

Global Markets Direct's, 'Vakzine Projekt Management GmbH - Product Pipeline Review - 2014', provides an overview of the Vakzine Projekt Management GmbH's pharmaceutical research and development focus.

Global Markets Direct's, 'Themis Bioscience GmbH - Product Pipeline Review - 2014', provides an overview of the Themis Bioscience GmbH's pharmaceutical research and development focus.

Global Markets Direct's, 'AbbVie Inc. - Product Pipeline Review - 2014', provides an overview of the AbbVie Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Progenics Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Progenics Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Global Markets Direct's, 'Gene Signal International SA - Product Pipeline Review - 2014', provides an overview of the Gene Signal International SA's pharmaceutical research and development focus.

Global Markets Direct's, 'Affibody AB - Product Pipeline Review - 2014', provides an overview of the Affibody AB's pharmaceutical research and development focus.

Global Markets Direct's, 'Zafgen Inc. - Product Pipeline Review - 2014', provides an overview of the Zafgen Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Vironova AB - Product Pipeline Review - 2014', provides an overview of the Vironova AB's pharmaceutical research and development focus.

Global Markets Direct's, 'Shin Poong Pharm Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Shin Poong Pharm Co., Ltd.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Furiex Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Furiex Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today it has finalized enrollment in its Phase II/III trial of CF101 for the treatment of psoriasis with over 300 patients through 17 clinical centers in the U.S., Israel and Europe. Top line results from the trial are expected in the first quarter of 2015.

Global Markets Direct's, 'Lpath, Inc. - Product Pipeline Review - 2014', provides an overview of the Lpath, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Vaccinex, Inc. - Product Pipeline Review - 2014', provides an overview of the Vaccinex, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Richter Gedeon Nyrt. - Product Pipeline Review - 2014', provides an overview of the Richter Gedeon Nyrt.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Easton Pharmaceuticals Inc. - Product Pipeline Review - 2014', provides an overview of the Easton Pharmaceuticals Inc.'s pharmaceutical research and development focus.